Basiliximab is a medication used to prevent organ rejection in individuals who have received a kidney transplant. It belongs to a class of drugs known as immunosuppressants.

After a kidney transplant, the body’s immune system may recognize the transplanted organ as foreign and mount an immune response against it, leading to organ rejection. Basiliximab works by blocking a specific type of immune cell called T lymphocytes, which play a key role in the rejection process.